(Q36407236)

14 August 2017

1 reference

title

Improving T cell therapy for cancer. (English)

1 reference

14 August 2017

2

Cliona M Rooney

1 reference

14 August 2017

Aaron E Foster

1

1 reference

PubMed ID

16503732

14 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

Expert Opinion on Biological Therapy

14 August 2017

1 reference

14 August 2017

6

1 reference

14 August 2017

3

1 reference

14 August 2017

215-229

1 reference

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

14 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

L-428 nodular sclerosing Hodgkin's cell secretes a unique transforming growth factor-beta active at physiologic pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Transforming growth factor beta 1 messenger RNA in Reed-Sternberg cells in nodular sclerosing Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

How tumors escape immune destruction and what we can do about it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Dendritic cells as a tool to induce anergic and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Central memory and effector memory T cell subsets: function, generation, and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Lessons from the study of T-cell differentiation in persistent human virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Lineage relationship and protective immunity of memory CD8 T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Expansion of human CMV-specific cytotoxic T lymphocytes to a clinical scale: a simple culture system using tetrameric HLA-peptide complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

B cells under influence: transformation of B cells by Epstein–Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Decorin gene transfer-mediated suppression of TGF-beta synthesis abrogates experimental malignant glioma growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Phase I trial of concurrent twice-weekly recombinant human interleukin-12 plus low-dose IL-2 in patients with melanoma or renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Construction and biological characterization of an interleukin-12 fusion protein (Flexi-12): delivery to acute myeloid leukemic blasts using adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Fas ligand expression in Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Expression of human tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Retroviral transduction of human peripheral blood lymphocytes with Bcl-X(L) promotes in vitro lymphocyte survival in pro-apoptotic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Interleukin-2-independent proliferation of human melanoma-reactive T lymphocytes transduced with an exogenous IL-2 gene is stimulation dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Burnet oration. T-cell survival and the role of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Interleukin-2: inception, impact, and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Bcl-2 overexpression enhances tumor-specific T-cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Immortalization of human CD8+ T cell clones by ectopic expression of telomerase reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Human telomerase reverse transcriptase-transduced human cytotoxic T cells suppress the growth of human melanoma in immunodeficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Bioterrorism. Smallpox vaccinations: how much protection remains?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Artificial T-cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Antigen-specific targeting of CD28-mediated T cell co-stimulation using chimeric single-chain antibody variable fragment-CD28 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Genetic engineering of T cell specificity for immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Transfer of specificity by murine alpha and beta T-cell receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Retroviral transduction of a T cell receptor specific for an Epstein-Barr virus-encoded peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Functional analysis of Fas signaling in vivo using synthetic inducers of dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

An inducible caspase 9 safety switch for T-cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Improved artificial death switches based on caspases and FADD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Multiple choices: regulation of memory CD8 T cell generation and homeostasis by interleukin (IL)-7 and IL-15

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

The peripheral T-cell pool: regulation by non-antigen induced proliferation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

T cell homeostatic proliferation elicits effective antitumor autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

CD4+CD25+ suppressor lymphocytes in the circulation of patients immunized against melanoma antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Adoptive transfer of autologous Epstein-Barr virus-specific cytotoxic T cells for nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Adoptive transfer of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T cells with in vitro antitumor activity boosts LMP2-specific immune response in a patient with EBV-related nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.3.215

21 January 2018

Identifiers

DOI

10.1517/14712598.6.3.215

1 reference

14 August 2017

1 reference

PubMed ID

16503732